The Effect of Age on Hypertension Control and Management

American Journal of Hypertension

Volumn 19, Issue 5, 2006, Pages 520-527

  Borzecki, Ann M ^a,b   Glickman, Mark E ^a,b   Kader, Boris ^a,b   Berlowitz, Dan R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

guidelines; Hypertension; outcome assessment; treatment

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL ASSISTANT; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33646084366     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.10.022     Document Type: Article

References (30)

1. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J Am Med Assoc 290 (2003) 199-206
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 265 (1991) 3255-3264
3. Amery A., Birkenhager W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Hamdy R., Joossens J.V., Lund-Johansen P., Petrie J., Tuomilehto J., and Williams B. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1 (1985) 1349-1354
4. Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
5. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., and Roccella E.J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. J Am Med Assoc 289 (2003) 2560-2572
6. Berlowitz D.R., Ash A.S., Hickey E.C., Friedman R.H., Glickman M., Kader B., and Moskowitz M.A. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339 (1998) 1957-1963
7. Cushman W.C., Ford C.E., Cutler J.A., Margolis K.L., Davis B.R., Grimm R.H., Black H.R., Hamilton B.P., Holland J., Nwachuku C., Papademetriou V., Probstfield J., Wright Jr. J.T., Alderman M.H., Weiss R.J., Piller L., Bettencourt J., and Walsh S.M. Success and predictors of blood pressure control in diverse North American settings. the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 4 (2002) 393-405
8. Goodwin J.S. Embracing complexity. a consideration of hypertension in the very old. J Gerontol A Biol Sci Med Sci 58 (2003) 653-658
9. Aronow W.S., Denson S., Hajjar I., Harris T.B., Lowenthal D.T., Michel J.P., Grab B., Perrenoud J.J., Newman A.B., and Thomas D.R. Commentary on "Embracing complexity: a consideration of hypertension in the very old". J Gerontol A Biol Sci Med Sci 58 (2003) 659-668
10. Gueyffier F., Bulpitt C., Boissel J.P., Schron E., Ekbom T., Fagard R., Casiglia E., Kerlikowske K., Coope J., and INDANA Group. Antihypertensive drugs in very old people. a subgroup meta-analysis of randomised controlled trials. Lancet 353 (1999) 793-796
11. Bulpitt C.J., Beckett N.S., Cooke J., Dumitrascu D.L., Gil-Extremera B., Nachev C., Nunes M., Peters R., Staessen J.A., and Thijs L. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 21 (2003) 2409-2417
12. Hyman D.J., and Pavlik V.N. Self-reported hypertension treatment practices among primary care physicians. blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 160 (2000) 2281-2286
13. Ekpo E.B., Shah I.U., Fernando M.U., and White A.D. Isolated systolic hypertension in the elderly. survey of practitioners' attitude and management. Gerontology 39 (1993) 207-214
14. Borzecki A.M., Wong A.T., Hickey E.C., Ash A.S., and Berlowitz D.R. Can we use automated data to assess quality of hypertension care?. Am J Manag Care 10 (2004) 473-479
15. VA Information Resource Center: Toolkit for new users of VA data. Available at: http://www.virec.research.med.va.gov/Support/Training-NewUsersToolkit/Toolkit.htm. (accessed March 10, 2005)
16. Borzecki A.M., Wong A.T., Hickey E.C., Ash A.S., and Berlowitz D.R. Identifying hypertension-related comorbidities from administrative data. what's the optimal approach?. Am J Med Qual 19 (2004) 201-206
17. Berlowitz D.R., Ash A.S., Hickey E.C., Kader B., Friedman R.H., and Moskowitz M.A. Profiling outcomes of ambulatory care. casemix affects perceived performance. Med Care 36 (1998) 928-933
18. Obesity. preventing and managing the global epidemic. Report of a WHO consultation (2000), World Health Organization, Geneva WHO Technical Report Series, No. 894
19. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies. development and validation. J Chron Dis 40 (1987) 373-383
20. Psaty B.M., Manolio T.A., Smith N.L., Heckbert S.R., Gottdiener J.S., Burke G.L., Weissfeld J., Enright P., Lumley T., Powe N., and Furberg C.D. Time trends in high blood pressure control and the use of antihypertensive medications in older adults. the Cardiovascular Health Study. Arch Intern Med 162 (2002) 2325-2332
21. Borzecki A.M., Wong A.T., Hickey E.C., Ash A.S., and Berlowitz D.R. Hypertension control. how well are we doing?. Arch Intern Med 163 (2003) 2705-2711
22. Wassertheil-Smoller S., Anderson G., Psaty B.M., Black H.R., Manson J., Wong N., Francis J., Grimm R., Kotchen T., Langer R., and Lasser N. Hypertension and its treatment in postmenopausal women. baseline data from the Women's Health Initiative. Hypertension 36 (2000) 780-789
23. Graves J.W., Darby C.H., Bailey K.R., and Sheps S.G. The effect of increasing age on hypertension control rates. Am J Hypertens 14 (2001) A232
24. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual blood pressure to vascular mortality. a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
25. Ogden L.G., He J., Lydick E., and Whelton P.K. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35 (2000) 539-543
26. Ren X.S., Kazis L.E., Lee A., Zhang H., and Miller D.R. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther 27 (2002) 47-56
27. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 288 (2002) 2981-2997
28. Wing L.M., Reid C.M., Ryan P., Beilin L.J., Brown M.A., Jennings G.L., Johnston C.I., McNeil J.J., Macdonald G.J., Marley J.E., Morgan T.O., West M.J., and Group ftSANBPS. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348 (2003) 583-592
29. Chobanian A.V. Control of hypertension-an important national priority. N Engl J Med 345 (2001) 534-535
30. Chaudhry S.I., Krumholz H.M., and Foody J.M. Systolic hypertension in older persons. J Am Med Assoc 292 (2004) 1074-1080